Mimedx (MDXG) Operating Expenses (2011 - 2026)

Mimedx has disclosed Operating Expenses across 16 years of filings, most recently posting $62.6 million for Q2 2026.

• In Q2 2026, Operating Expenses fell 7.26% year-over-year to $62.6 million; the TTM figure through Jun 2026 stood at $270.5 million (up 7.41% YoY), while the FY2025 annual figure was $281.3 million, up 18.47% from the prior year.
• Operating Expenses came in at $62.6 million for Q2 2026 at Mimedx, up from $57.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $77.8 million in Q4 2025 to a low of $45.1 million in Q4 2022.
• Average Operating Expenses over 5 years is $60.4 million, with a median of $58.6 million recorded in 2023.
• Year-over-year, Operating Expenses advanced 28.83% in 2025 and retreated 9.36% in 2026.
• Over 5 years, Operating Expenses stood at $45.1 million in 2022, then increased by 25.89% to $56.8 million in 2023, then climbed by 13.79% to $64.6 million in 2024, then gained by 20.46% to $77.8 million in 2025, then declined by 19.63% to $62.6 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $62.6 million in Q2 2026, $57.4 million in Q1 2026, and $77.8 million in Q4 2025.